SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) Fundamental Analysis & Valuation

BIT:1SOBI • SE0000872095

Current stock price

35.98 EUR
+1.02 (+2.92%)
Last:

This 1SOBI.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1SOBI.MI Profitability Analysis

1.1 Basic Checks

  • 1SOBI had positive earnings in the past year.
  • In the past year 1SOBI had a positive cash flow from operations.
  • 1SOBI had positive earnings in each of the past 5 years.
  • In the past 5 years 1SOBI always reported a positive cash flow from operatings.
1SOBI.MI Yearly Net Income VS EBIT VS OCF VS FCF1SOBI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B

1.2 Ratios

  • 1SOBI's Return On Assets of 0.71% is fine compared to the rest of the industry. 1SOBI outperforms 67.47% of its industry peers.
  • 1SOBI has a better Return On Equity (1.27%) than 71.08% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.73%, 1SOBI belongs to the best of the industry, outperforming 90.36% of the companies in the same industry.
  • 1SOBI had an Average Return On Invested Capital over the past 3 years of 9.46%. This is in line with the industry average of 11.34%.
  • The last Return On Invested Capital (13.73%) for 1SOBI is above the 3 year average (9.46%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.71%
ROE 1.27%
ROIC 13.73%
ROA(3y)3.04%
ROA(5y)3.93%
ROE(3y)6.01%
ROE(5y)7.9%
ROIC(3y)9.46%
ROIC(5y)9.35%
1SOBI.MI Yearly ROA, ROE, ROIC1SOBI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • 1SOBI has a Profit Margin of 1.69%. This is in the better half of the industry: 1SOBI outperforms 69.88% of its industry peers.
  • In the last couple of years the Profit Margin of 1SOBI has declined.
  • The Operating Margin of 1SOBI (28.37%) is better than 83.13% of its industry peers.
  • 1SOBI's Operating Margin has been stable in the last couple of years.
  • 1SOBI's Gross Margin of 78.90% is fine compared to the rest of the industry. 1SOBI outperforms 67.47% of its industry peers.
  • In the last couple of years the Gross Margin of 1SOBI has remained more or less at the same level.
Industry RankSector Rank
OM 28.37%
PM (TTM) 1.69%
GM 78.9%
OM growth 3Y5.61%
OM growth 5Y-0.63%
PM growth 3Y-50.6%
PM growth 5Y-39.72%
GM growth 3Y1.02%
GM growth 5Y0%
1SOBI.MI Yearly Profit, Operating, Gross Margins1SOBI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1SOBI.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1SOBI is creating value.
  • Compared to 1 year ago, 1SOBI has more shares outstanding
  • 1SOBI has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1SOBI has been reduced compared to a year ago.
1SOBI.MI Yearly Shares Outstanding1SOBI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1SOBI.MI Yearly Total Debt VS Total Assets1SOBI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 3.98 indicates that 1SOBI is not in any danger for bankruptcy at the moment.
  • 1SOBI has a better Altman-Z score (3.98) than 68.67% of its industry peers.
  • 1SOBI has a debt to FCF ratio of 2.12. This is a good value and a sign of high solvency as 1SOBI would need 2.12 years to pay back of all of its debts.
  • The Debt to FCF ratio of 1SOBI (2.12) is better than 87.95% of its industry peers.
  • A Debt/Equity ratio of 0.14 indicates that 1SOBI is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.14, 1SOBI is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 2.12
Altman-Z 3.98
ROIC/WACC2.05
WACC6.7%
1SOBI.MI Yearly LT Debt VS Equity VS FCF1SOBI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B

2.3 Liquidity

  • 1SOBI has a Current Ratio of 0.90. This is a bad value and indicates that 1SOBI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.90, 1SOBI is not doing good in the industry: 69.88% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.59 indicates that 1SOBI may have some problems paying its short term obligations.
  • 1SOBI has a worse Quick ratio (0.59) than 78.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.59
1SOBI.MI Yearly Current Assets VS Current Liabilites1SOBI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1SOBI.MI Growth Analysis

3.1 Past

  • The earnings per share for 1SOBI have decreased strongly by -88.99% in the last year.
  • Measured over the past years, 1SOBI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -32.38% on average per year.
  • Looking at the last year, 1SOBI shows a quite strong growth in Revenue. The Revenue has grown by 8.49% in the last year.
  • 1SOBI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.10% yearly.
EPS 1Y (TTM)-88.99%
EPS 3Y-49.88%
EPS 5Y-32.38%
EPS Q2Q%32.84%
Revenue 1Y (TTM)8.49%
Revenue growth 3Y14.54%
Revenue growth 5Y13.1%
Sales Q2Q%5.19%

3.2 Future

  • 1SOBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 80.96% yearly.
  • 1SOBI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.72% yearly.
EPS Next Y1404.9%
EPS Next 2Y335.1%
EPS Next 3Y174.39%
EPS Next 5Y80.96%
Revenue Next Year11.39%
Revenue Next 2Y12.27%
Revenue Next 3Y10.69%
Revenue Next 5Y8.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1SOBI.MI Yearly Revenue VS Estimates1SOBI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
1SOBI.MI Yearly EPS VS Estimates1SOBI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

6

4. 1SOBI.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1SOBI is valuated quite expensively with a Price/Earnings ratio of 299.83.
  • Based on the Price/Earnings ratio, 1SOBI is valued a bit cheaper than the industry average as 68.67% of the companies are valued more expensively.
  • 1SOBI is valuated expensively when we compare the Price/Earnings ratio to 25.96, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 19.85, 1SOBI is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, 1SOBI is valued cheaply inside the industry as 83.13% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, 1SOBI is valued at the same level.
Industry RankSector Rank
PE 299.83
Fwd PE 19.85
1SOBI.MI Price Earnings VS Forward Price Earnings1SOBI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SOBI indicates a rather cheap valuation: 1SOBI is cheaper than 89.16% of the companies listed in the same industry.
  • 80.72% of the companies in the same industry are more expensive than 1SOBI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.45
EV/EBITDA 8.18
1SOBI.MI Per share data1SOBI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1SOBI has a very decent profitability rating, which may justify a higher PE ratio.
  • 1SOBI's earnings are expected to grow with 174.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y335.1%
EPS Next 3Y174.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1SOBI.MI Dividend Analysis

5.1 Amount

  • 1SOBI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1SOBI.MI Fundamentals: All Metrics, Ratios and Statistics

SWEDISH ORPHAN BIOVITRUM AB

BIT:1SOBI (3/4/2026, 7:00:00 PM)

35.98

+1.02 (+2.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-05
Earnings (Next)04-27
Inst Owners37.33%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap12.86B
Revenue(TTM)28.24B
Net Income(TTM)478.00M
Analysts80
Price Target41.26 (14.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-123.13%
Min EPS beat(2)-270.86%
Max EPS beat(2)24.59%
EPS beat(4)3
Avg EPS beat(4)-54.43%
Min EPS beat(4)-270.86%
Max EPS beat(4)24.59%
EPS beat(8)7
Avg EPS beat(8)-14.12%
EPS beat(12)8
Avg EPS beat(12)-15.07%
EPS beat(16)11
Avg EPS beat(16)-6.36%
Revenue beat(2)0
Avg Revenue beat(2)-3.75%
Min Revenue beat(2)-4.6%
Max Revenue beat(2)-2.9%
Revenue beat(4)1
Avg Revenue beat(4)-2.12%
Min Revenue beat(4)-4.6%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)2.19%
Revenue beat(12)6
Avg Revenue beat(12)2.8%
Revenue beat(16)10
Avg Revenue beat(16)3.11%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)-6.72%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-2.48%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 299.83
Fwd PE 19.85
P/S 4.88
P/FCF 25.45
P/OCF 16.08
P/B 3.65
P/tB N/A
EV/EBITDA 8.18
EPS(TTM)0.12
EY0.33%
EPS(NY)1.81
Fwd EY5.04%
FCF(TTM)1.41
FCFY3.93%
OCF(TTM)2.24
OCFY6.22%
SpS7.38
BVpS9.85
TBVpS-2.97
PEG (NY)0.21
PEG (5Y)N/A
Graham Number5.16
Profitability
Industry RankSector Rank
ROA 0.71%
ROE 1.27%
ROCE 15.6%
ROIC 13.73%
ROICexc 14.01%
ROICexgc 566.89%
OM 28.37%
PM (TTM) 1.69%
GM 78.9%
FCFM 19.17%
ROA(3y)3.04%
ROA(5y)3.93%
ROE(3y)6.01%
ROE(5y)7.9%
ROIC(3y)9.46%
ROIC(5y)9.35%
ROICexc(3y)9.64%
ROICexc(5y)9.57%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.12%
ROCE(5y)10.97%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y10.49%
ROICexc growth 5Y5.93%
OM growth 3Y5.61%
OM growth 5Y-0.63%
PM growth 3Y-50.6%
PM growth 5Y-39.72%
GM growth 3Y1.02%
GM growth 5Y0%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 2.12
Debt/EBITDA 0.3
Cap/Depr 31.23%
Cap/Sales 11.17%
Interest Coverage 11.04
Cash Conversion 47.3%
Profit Quality 1132.22%
Current Ratio 0.9
Quick Ratio 0.59
Altman-Z 3.98
F-Score6
WACC6.7%
ROIC/WACC2.05
Cap/Depr(3y)89.13%
Cap/Depr(5y)69.38%
Cap/Sales(3y)15.02%
Cap/Sales(5y)11.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.99%
EPS 3Y-49.88%
EPS 5Y-32.38%
EPS Q2Q%32.84%
EPS Next Y1404.9%
EPS Next 2Y335.1%
EPS Next 3Y174.39%
EPS Next 5Y80.96%
Revenue 1Y (TTM)8.49%
Revenue growth 3Y14.54%
Revenue growth 5Y13.1%
Sales Q2Q%5.19%
Revenue Next Year11.39%
Revenue Next 2Y12.27%
Revenue Next 3Y10.69%
Revenue Next 5Y8.72%
EBIT growth 1Y37.66%
EBIT growth 3Y20.97%
EBIT growth 5Y12.39%
EBIT Next Year72.66%
EBIT Next 3Y26.31%
EBIT Next 5Y16.54%
FCF growth 1Y23.48%
FCF growth 3Y20.42%
FCF growth 5Y38.19%
OCF growth 1Y15.93%
OCF growth 3Y23.24%
OCF growth 5Y11.7%

SWEDISH ORPHAN BIOVITRUM AB / 1SOBI.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1SOBI.MI.


What is the valuation status of SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI). This can be considered as Fairly Valued.


What is the profitability of 1SOBI stock?

SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for 1SOBI stock?

The Price/Earnings (PE) ratio for SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) is 299.83 and the Price/Book (PB) ratio is 3.65.


What is the earnings growth outlook for SWEDISH ORPHAN BIOVITRUM AB?

The Earnings per Share (EPS) of SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) is expected to grow by 1404.9% in the next year.